Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 1 Sep 21 424B3 Prospectus supplement
- 16 Aug 21 424B4 Prospectus supplement with pricing info
- 13 Aug 21 POS EX Additional exhibits for listing
- 13 Aug 21 EFFECT Notice of effectiveness
- 5 Aug 21 S-1/A IPO registration (amended)
- 12 Jul 21 FWP Free writing prospectus
- 9 Jul 21 S-1/A IPO registration (amended)
-
2 Jul 21 S-1/A IPO registration (amended)
- 10 Jun 21 S-1 IPO registration
DRMA similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in Amendment No. 1 to this Registration Statement on Form S-1 of our report dated April 2, 2021, with respect to the financial statements of Dermata Therapeutics, Inc. as of December 31, 2020 and 2019, and for the years then ended (which includes an explanatory paragraph related to the existence of substantial doubt about the Company’s ability to continue as a going concern), and to the reference to us under the heading “Experts” included in this Registration Statement and accompanying prospectus on Form S-1.
/s/ Mayer Hoffman McCann P.C.
San Diego, California
July 2, 2021